(Q34265962)

1 August 2017

title

Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo (English)

1 reference

1 August 2017

8

David B Weiner

1 reference

1 August 2017

Karuppiah Muthumani

1

1 reference

1 August 2017

Donghui Zhang

2

1 reference

1 August 2017

Nathanael S Dayes

3

1 reference

1 August 2017

Daniel S Hwang

4

1 reference

1 August 2017

Sandra A Calarota

5

1 reference

1 August 2017

Andrew Y Choo

6

1 reference

1 August 2017

Jean D Boyer

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

1 August 2017

number of pages

13

1 reference

inferred from page(s)

published in

Virology

1 reference

1 August 2017

volume

314

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

134-146

1 reference

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Ground zero: AIDS research in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Is AIDS in Africa a distinct disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Africa boosts AIDS vaccine R&D.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

HIV-1: fifteen proteins and an RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Immunologic control of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Diversity considerations in HIV-1 vaccine selection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Human immunodeficiency virus type 1 subtypes differ in disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

The global epidemiology of HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

HIV-1 diversity and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Identification of a novel posttranscriptional regulatory element by using a rev- and RRE-mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Rous sarcoma virus DR posttranscriptional elements use a novel RNA export pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle b

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Role of Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) in the propagation of MPMV vectors by genetic complementation using homologous/heterologous env genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900459-8

7 January 2021

10.1016/S0042-6822(03)00459-8

Identifiers

DOI

1 reference

1 August 2017

1 reference